Who Just Raised

Bioventrix, Inc.

Mansfield, MA · Biotechnology

Bioventrix, Inc. is a biotechnology company based in Mansfield, Massachusetts. In a Form D filed with the SEC on October 8, 2026, it reported raising $1,200,000 from 6 investors as part of an offering of up to $3,000,000. The first sale in the offering took place on September 29, 2026.

OUR VISION: Extend Life Span and Improve Quality of Life for Heart Failure Patients OUR VISION Extending Life Span and Improving Quality of Life for Heart Failure Patients How Revivent Therapy May…

Website
bioventrix.com
Amount raised
$1,200,000
Offering size
$3,000,000
Investors so far
6
Minimum investment
$50,000
First sale
September 29, 2026
Securities offered
Debt, Options or warrants, Securities issuable on exercise or conversion
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Mansfield, Massachusetts
Incorporated
Delaware
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $1,200,000 $3,000,000 6 SEC filing
D/A (amendment) $2,965,000 $10,000,000 25 SEC filing
D/A (amendment) $2,765,000 $10,000,000 9 SEC filing

Figures come from the company's own filings with the SEC and are shown as reported. How to read a Form D.

Other health care raises in Massachusetts

Company Location Sector Raised Target Filed
Axelyf, Inc. Chestnut Hill, MA Health Care $2.6M $2.7M
Soterya, Inc. Boston, MA Health Care $850K $2M
Opus KSD, Inc. Pembroke, MA Health Care $681K $681K
Xact Bio, Inc. Boston, MA Health Care $10M $18M
Way Biosolutions, Inc. Cambridge, MA Health Care $2M $2M
AutoIVF, Inc. Natick, MA Health Care $1.5M $1.5M